ASP Isotopes Nears Helium Production, Advances Stable Isotope Growth

ASP Isotopes (NASDAQ:ASPI) expects several of its business units to enter commercial production or expand output over the next six months, with Chief Executive Officer Paul Mann highlighting progress in helium, liquefied natural gas, stable isotopes and radiopharmaceuticals during a conference presentation. Mann said the company’s objective is to strengthen access to critical materials used in electronics, nuclear medicine and nuclear energy. Its operations include PET Labs, stable-isotope enrichment facilities in South Africa, the Renergen helium and energy business, and Quantum Leap Energy, which is focused on fuels including high-assay low-enriched uranium and lithium isotopes. Renergen…